Bangkok Bank

Bangkok Bank, established in 1944, is a prominent commercial bank in Thailand, recognized for its extensive range of banking and financial services. The bank serves a diverse clientele across East Asia, leveraging its local expertise to facilitate their growth and development. Bangkok Bank's operations include a significant focus on loans to customers, which constitute the majority of its assets, alongside investments and interbank market activities. The bank is also involved in various financial instruments, including derivatives, and maintains a portfolio of properties and equipment. With a commitment to supporting its clients, Bangkok Bank has built a strong reputation and continues to play a vital role in the region's financial landscape.

Chaiyarit Anuchitworawong

Senior Executive Vice President, Investor Relations

Kirati Laisathit

Executive Vice President and Portfolio Manager

Kullawee Mingkwansuk

Assistant Vice President of Investor Relations

Sumataya Pholvaddhana

Vice President, Investor Relations

8 past transactions

Contour

Series A in 2021
Contour is building the world’s open trade finance network. By focusing on collaboration and leveraging new technologies we are dissolving the barriers to seamless trade. Our networks of banks, corporates, services and partnerships enable the instant flow of trusted data across the world’s trade routes and current fragmented ecosystems.

Red Date Technology

Series A in 2021
Red Date Technology one of the four founding members of the Blockchain-based Service Network (BSN).

Halodoc

Series C in 2021
PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, founded in 2016. It connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its services. Users can engage with medical professionals via video calls, voice calls, and chat, facilitating real-time online consultations. The platform also allows patients to order laboratory tests that can be conducted at home and helps them locate nearby hospitals and clinics. Additionally, HaloDoc provides access to licensed medical laboratory services and a medical delivery service known as ApotikAntar, further enhancing the convenience and accessibility of healthcare for its users.

Ajaib

Series A in 2021
Ajaib is an online wealth management platform based in Jakarta, Indonesia, that facilitates automatic saving and investing for its users. Founded in 1990, the platform enables Indonesians to buy and sell a variety of financial products, including stocks, exchange-traded funds (ETFs), and mutual funds. Ajaib aims to simplify the investment process, making it accessible for a broader audience in Indonesia.

Ninja Van

Series D in 2020
Ninja Van is the growing startup in the logistics space, solving the last mile problem via a multitude of strategic tie-ups and a cutting edge technology stack via our reactive and distributed systems. We firmly believe that optimization of logistics in Asia revolves around a routing software layer controlling legacy assets while concurrently building our own hardware, infrastructure and assets if necessary to enable the new age of logistics. Imagine scalable capacity on demand. Imagine routing and sharing of corporate fleets. Imagine affordable multi-modal same-day courier.

Contour

Corporate Round in 2020
Contour is building the world’s open trade finance network. By focusing on collaboration and leveraging new technologies we are dissolving the barriers to seamless trade. Our networks of banks, corporates, services and partnerships enable the instant flow of trusted data across the world’s trade routes and current fragmented ecosystems.

PermataBank

Acquisition in 2019
PermataBank is a provides commercial and foreign exchange banking services. PermataBank comes from an innovation to be a partner who gives the best solution in reaching dreams easily for you and your family.

Humacyte

Series B in 2015
Humacyte, Inc. is a medical research and development company headquartered in Morrisville, North Carolina, established in 2004. The company specializes in creating human tissue-based products aimed at regenerative medicine and vascular surgery. Its core technology involves the design of acellular extracellular matrices derived from banked vascular smooth muscle cells, which are decellularized to minimize the risk of rejection. These innovations are utilized to produce tissue-engineered grafts for patients requiring vascular repair or replacement, positioning Humacyte as a key player in addressing vascular diseases and enhancing surgical outcomes.